SHL Medical returns to Pharmapack Europe 2023
SHL Medical is opening 2023 with our participation in Pharmapack Europe. We will be returning to Paris Expo Porte de Versailles on February 1-2 to catch up with other industry enthusiasts, unlock new business opportunities, and grow our community further.
This year, we seek to delve deeper into the large-volume/high-dose self-injection solutions with our cartridge-based Maggie® and Maggie® 5.0 autoinjectors. Since its debut last year, Maggie 5.0 has captured the attention of pharma professionals within the drug delivery and packaging industry. This two-step autoinjector opens new pathways for autoinjectors to accommodate a wider variety of formulation characteristics, such as large volumes, high viscosities, suspension drugs, as well as supporting formulations sensitive to contact with steel and air.
A finalist of the 2022 CPHI Pharma Awards, Maggie 5.0 is built with SHL’s market-proven Needle Isolation Technology (NIT®). The inclusion of NIT within the cap of the device eliminates the need for users to manually attach the needle, thereby reducing the risks of foreign particle contamination and needle-stick injury. Furthermore, the technology supports complete control of cannula gauge and length to enable target injection time and depth. This allowed NIT to pave the way for safe and intuitive large-volume/high-dose autoinjectors.
Returning once again to Pharmapack this year is one of our most versatile devices, Molly® modular platform autoinjector. Molly autoinjectors represent the limitless potentials made possible via modular technology, SHL’s well-established infrastructure, and the wealth of industry knowledge stemming from experiences and long-standing collaborations with our partners. Together, these aspects enable the continuous expansion of Molly’s proven technology to meet new market demands and improve patient outcomes.
As we continue to celebrate Molly’s success in Pharmapack 2023, we are keen to reemphasize the value of Molly – its flexibility to adjust and response to industry advances, from lifecycle management, digitalization, to sustainability. To date, Molly autoinjectors have given patients in at least 33 countries access to self-injectable treatments in the comfort of their homes.
We are eager to welcome participants of Pharmapack Europe 2023 at Stand #C64 where our team will be on-site and ready to introduce SHL’s comprehensive products and services and answer any of your inquiries.
Where : Paris Expo Porte de Versailles, Paris, France | Stand #C64
When : Feb 1-2
